Inhibition of signaling via erbB-receptors by antibodies that target the Lewis Y-antigen

Inhibition of signaling via erbB-receptors by antibodies that target the Lewis Y-antigen

Bibliographic Details
Main Authors:	Himmler G, Freissmuth M, Farhan H, Klinger M, Waxenecker G, Janzek E, Mudde GC, Loibner H
Format:	Article
Language:	English
Published:	BMC 2004-07-01
Series:	Cancer Cell International

Similar Items

Immunization of Rhesus monkeys with a conjugate vaccine IGN402 induces immune responses against carbohydrate and protein antigens, and cancer cells
by: Nechansky A, et al.
Published: (2004-07-01)

Analysis of ErbB Receptors: Regulation of ErbB-1 Kinase Activation and Localization of ErbB-4 to Membrane Microdomains
by: Thiel, Kristina Wyatt
Published: (2007)

Modulation of ErbB2 blockade in ErbB2-positive cancers: the role of ErbB2 Mutations and PHLDA1.
by: Guangyuan Li, et al.
Published: (2014-01-01)

Blockade of ErbB2 and PD-L1 using a bispecific antibody to improve targeted anti-ErbB2 therapy
by: Deepak Mittal, et al.
Published: (2019-11-01)

ErbB activation signatures as potential biomarkers for anti-ErbB3 treatment in HNSCC.
by: Diego Alvarado, et al.
Published: (2017-01-01)

Spinal nerve injury causes upregulation of ErbB2 and ErbB3 receptors in rat dorsal root ganglia
by: Mizobuchi S, et al.
Published: (2013-02-01)

Inhibition of ErbB kinase signalling promotes resolution of neutrophilic inflammation
by: Atiqur Rahman, et al.
Published: (2019-10-01)

Proliferation of colorectal cancer is promoted by two signaling transduction expression patterns: ErbB2/ErbB3/AKT and MET/ErbB3/MAPK.
by: Yong-Liang Yao, et al.
Published: (2013-01-01)

Targeting ErbB3 Receptor in Cancer with Inhibitory Antibodies from Llama
by: Igor E. Eliseev, et al.
Published: (2021-08-01)

Anti-tubulin drugs conjugated to anti-ErbB antibodies selectively radiosensitize
by: Stephen R. Adams, et al.
Published: (2016-10-01)

ErbB1 and ErbB3 co-over expression as a prognostic factor in gastric cancer
by: Meysam Moghbeli, et al.
Published: (2019-01-01)

Chromatin Modifications Sequentially Enhance ErbB2 Expression in ErbB2-Positive Breast Cancers
by: Sathish Kumar Mungamuri, et al.
Published: (2013-10-01)

The erbB oncogene family in human bladder cancer
by: Rajjayabun, Paul H.
Published: (2004)

Development of ErbB2-Targeting Liposomes for Enhancing Drug Delivery to ErbB2-Positive Breast Cancer
by: Sho Ueno, et al.
Published: (2020-06-01)

Betacellulin-induced beta cell proliferation and regeneration is mediated by activation of ErbB-1 and ErbB-2 receptors.
by: Yoon Sin Oh, et al.
Published: (2011-01-01)

Ontogeny of the Neuregulin Receptor ErbB4 in the Rat Forebrain and Phenotypic Characterization of ErbB4-Deficienct Mice
by: Hau-Jie Yau, et al.
Published: (2006)

The role of ErbB3 in melanocyte development
by: Fernandez, Irina
Published: (2006)

ErbB receptor regulation of growth in ovarian cancer
by: Gilmour, Lynn M. R.
Published: (2002)

The Role of Periostin in ErbB2-Driven Mammary Tumorigenesis and its Gene Regulation in ErbB2+ Cancer Cells
by: Labrèche, Cédrik
Published: (2021)

Melatonin upregulates ErbB1 and ErbB4, two primary implantation receptors, in pre-implantation mouse embryos
by: Ghazaleh Moshkdanian, et al.
Published: (2017-06-01)

Valproic acid exhibits anti-tumor activity selectively against EGFR/ErbB2/ErbB3-coexpressing pancreatic cancer via induction of ErbB family members-targeting microRNAs
by: Tingting Lin, et al.
Published: (2019-04-01)

Betacellulin-Induced α-Cell Proliferation Is Mediated by ErbB3 and ErbB4, and May Contribute to β-Cell Regeneration
by: Young-Sun Lee, et al.
Published: (2021-01-01)

BRAF mutant colorectal cancer: ErbB2 expression levels as predictive factor for the response to combined BRAF/ErbB inhibitors
by: Evelina Miele, et al.
Published: (2020-02-01)

Combined inhibition of ErbB1/2 and Notch receptors effectively targets breast ductal carcinoma in situ (DCIS) stem/progenitor cell activity regardless of ErbB2 status.
by: Gillian Farnie, et al.
Published: (2013-01-01)

Natural Products as Chemopreventive Agents by Potential Inhibition of the Kinase Domain in ErbB Receptors
by: Maria Olivero-Acosta, et al.
Published: (2017-02-01)

Proteolytic processing of ErbB4 in breast cancer.
by: Maija Hollmén, et al.
Published: (2012-01-01)

Investigations into the role of ErbB4 in mouse development
by: Tidcombe, Hester Gabrielle Anne
Published: (2003)

The receptor ErbB4 and its downstream signalling
by: Lynch, Danielle Kirsty
Published: (1999)

Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition
by: Flores Juana M, et al.
Published: (2010-07-01)

Genetically modified natural killer cells specifically recognizing the tumor-associated antigens ErbB2/HER2 and EpCAM
by: Uherek B, et al.
Published: (2004-07-01)

Exogenous HGF Bypasses the Effects of ErbB Inhibition on Tumor Cell Viability in Medulloblastoma Cell Lines.
by: Walderik W Zomerman, et al.
Published: (2015-01-01)

Prognostic value of ErbB2/HER2 in human meningiomas.
by: Magnus B Arnli, et al.
Published: (2018-01-01)

Photo-activated psoralen binds the ErbB2 catalytic kinase domain, blocking ErbB2 signaling and triggering tumor cell apoptosis.
by: Wenle Xia, et al.
Published: (2014-01-01)

Transcriptional profiling of ErbB signalling in mammary luminal epithelial cells - interplay of ErbB and IGF1 signalling through IGFBP3 regulation
by: Worthington Jenny, et al.
Published: (2010-09-01)

Production, characterisation and clinical application of a monoclonal antibody to the human c-erbB-2 oncoprotein
by: Corbett, Ian Porter
Published: (1991)

Functional expression of a single-chain antibody to ErbB-2 in plants and cell-free systems
by: Benevolo Maria, et al.
Published: (2006-09-01)

Nuclear ErbB2 represses DEPTOR transcription to inhibit autophagy in breast cancer cells
by: Yanli Bi, et al.
Published: (2021-04-01)

Inhibition of eIF2α dephosphorylation inhibits ErbB2-induced deregulation of mammary acinar morphogenesis
by: Avivar-Valderas Alvaro, et al.
Published: (2009-09-01)

c-erbB-2 expression and nuclear pleomorphism in canine mammary tumors
by: Dutra A.P., et al.
Published: (2004-01-01)

Treatment of ErbB2 breast cancer by mitochondrial targeting
by: Sophia Eldad, et al.
Published: (2020-07-01)